pI: 5.8811 |
Length (AA): 174 |
MW (Da): 17665 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There is 1 model calculated for this protein. More info on
this model, including the
model itself is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
1 | 174 | 1v3w (A) | 1 | 173 | 39.00 | 0 | 1 | 1.6111 | -1.3 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | Dormant phase. | murphy |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | Dormant phase. | hasan |
murphy | Identification of gene targets against dormant phase Mycobacterium tuberculosis infections. |
hasan | Prioritizing genomic drug targets in pathogens: application to Mycobacterium tuberculosis. |
Ortholog group members (OG5_129074)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G19580 | gamma carbonic anhydrase 1 |
Arabidopsis thaliana | AT1G47260 | gamma carbonic anhydrase 2 |
Dictyostelium discoideum | DDB_G0278597 | bacterial transferase hexapeptide repeat-containing protein |
Dictyostelium discoideum | DDB_G0288155 | trimeric LpxA-like domain-containing protein |
Escherichia coli | b1400 | putative hexapeptide repeat acetyltransferase |
Escherichia coli | b0035 | stimulator of CaiD and CaiB enzyme activities |
Escherichia coli | b3279 | bacterial transferase hexapeptide domain protein |
Entamoeba histolytica | EHI_004840 | bacterial transferase hexapeptide family protein |
Leishmania braziliensis | LbrM.19.0290 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_110030.1 | Bacterial transferase hexapeptide (six repeats), putative |
Leishmania infantum | LinJ.11.0030 | hypothetical protein, conserved |
Leishmania major | LmjF.11.0030 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.11.0030 | hypothetical protein, conserved |
Mycobacterium tuberculosis | Rv3525c | Possible siderophore-binding protein |
Mycobacterium ulcerans | MUL_4088 | hypothetical protein |
Oryza sativa | 4351619 | Os12g0169700 |
Oryza sativa | 4344079 | Os07g0642900 |
Schmidtea mediterranea | mk4.053213.02 | |
Trypanosoma brucei gambiense | Tbg972.11.8170 | hypothetical protein, conserved |
Trypanosoma brucei | Tb11.02.5070b | hypothetical protein, conserved |
Trypanosoma congolense | TcIL3000_0_00830 | Bacterial transferase hexapeptide (six repeats), putative |
Trypanosoma cruzi | TcCLB.510381.30 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.506905.30 | hypothetical protein, conserved |
Wolbachia endosymbiont of Brugia malayi | Wbm0289 | carbonic anhydrase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu3586 this record | Mycobacterium tuberculosis | non-essential | nmpdr |
Tb11.02.5070 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.02.5070 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb11.02.5070 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.02.5070 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
b0035 | Escherichia coli | non-essential | goodall |
b1400 | Escherichia coli | non-essential | goodall |
b3279 | Escherichia coli | non-essential | goodall |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Methanosarcina thermophila | Carbonic anhydrase | Compounds | References |